[Studies on mutation of rifampicin-resistant genes in M. tuberculosis].
To understand mutation of rifampicin-resistant genes in M. tuberculosis clinical isolates, and to develop a new method for detecting drug resistance. Analyzing the rpoB genes in 50 M. tuberculosis clinical isolates with polymerase chain reaction-single-stranded conformation polymorphism (PCR-SS-CP) and PCR-direct sequencing(PCR-DS) techniques. M. tuberculosis strain H37Rv was used as control. Of 3 drug-sensitive isolates and 2 non-rifampicin-resistant isolates selected, only 1 drug-sensitive isolate with abnormal rpoB SSCP profile had TCG-->TTG mutation at codon 531. Of 45 rifampicin-resistant isolates, 35 isolates with abnormal SSCP profiles had mutations in rpoB sequences, in which 14 isolates displayed TCG-->TTG or TGG or TAC mutations at codon 531, 14 had CAC-->TAC or GAC or CCC or CTC or GTC mutations at codon 526, 2 had GAC-->GTC or TAC mutations at codon 516, 2 had two point mutations, and 3 had different rpoB sequences from that of M. tuberculosis. Resistance to rifampicin in most M. tuberculosis isolates is due to the mutations on the genes encoding the RNA polymerase subunit (rpoB). PCR-SSCP and PCR-DS techniques might become simple, rapid and reliable diagnostic tests for rifampicin resistance in clinical isolates.